BioCentury
ARTICLE | Company News

SkylineDx sales and marketing update

August 17, 2015 7:00 AM UTC

SkylineDx launched the MMprofiler test in Europe to predict prognosis of patients with multiple myeloma (MM). The micro-array based gene expression profiling assay measures the activity of 92 genes re...